Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GSNOR inhibitors(S-nitrosoglutathione reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22N4O3 |
InChIKeyYVPGZQLRPAGKLA-UHFFFAOYSA-N |
CAS Registry1208315-24-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 1 | US | 01 Feb 2014 | |
Asthma | Phase 1 | US | 01 Mar 2011 | |
Inflammatory Bowel Diseases | Phase 1 | US | - | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | US | - | |
Brain Cancer | Preclinical | US | 01 Jul 2017 |
Phase 1 | 66 | cbdyhyqcuq(uohivufgil) = rhsbexughy errbripfdl (ajrbuwldpv, egdffrlgdl - nggnpglhkb) View more | - | 24 Nov 2014 | |||
Phase 1 | - | 41 | Placebo | xelfmoeykj(bjvjmqylwq) = bpfsitndce hslevvzaqp (litewmixcw, patvaxwrqs - suvewieptt) View more | - | 07 Mar 2014 |